| Gina L D'arco, RPH | |
|
403 Sicklerville Rd, Sicklerville, NJ 08081-1833 | |
| (856) 875-8156 | |
| Not Available |
| Full Name | Gina L D'arco |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 403 Sicklerville Rd, Sicklerville, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124148309 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 28RI02629200 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Gina L D'arco, RPH 223 Winterberry Ln, Hammonton, NJ 08037-2345 Ph: (609) 561-8299 | Gina L D'arco, RPH 403 Sicklerville Rd, Sicklerville, NJ 08081-1833 Ph: (856) 875-8156 |
News Archive
As attempts to gain support for health reform across party lines and from stoic interest groups like the American Medical Association continue, House leaders are seeking to rally centrist members of their own caucus, CQ Politics reports.
iSOFT Group Limited, one of the world's largest healthcare information technology companies, today announced that it will showcase its suite of innovative solutions that focus on interoperability at the HIMSS health IT conference in Atlanta in the US from March 1-4, 2010.
Sagent Pharmaceuticals, Inc., a privately-held specialty pharmaceutical company, today announced U.S. FDA's approval of four presentations of midazolam injection, USP, a general anesthetic. Sagent expects to launch midazolam, which will be offered in latex-free vials, in 2011. According to 2010 IMS data, the annual U.S. market for injectable midazolam approximated $52 million.
Cylene Pharmaceuticals, Inc. announced today the initiation of a Phase I clinical trial of their first-in-class, oral CK2 inhibitor CX-4945 in patients with multiple myeloma. Cylene also announced the simultaneous closing of a $12 million financing with participation from existing investors including Sanderling Ventures, HBM BioVentures (Cayman) Ltd., Novartis BioVenture Fund, BioVentures Investors, Lilly Ventures, Mitsui & Co. and Morningside Venture Investments Ltd.
› Verified 4 days ago
Mrs. Wendi Ann Brown, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 515 Berlin Cross Keys Rd, Pharmacy Department, Sicklerville, NJ 08081 Phone: 856-728-6052 Fax: 856-728-4945 | |
Mrs. Donna Driscoll, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 515 Berlin Cross Keys Rd, Sicklerville, NJ 08081 Phone: 856-728-2189 | |
Dr. Anne Edelman, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 589 Berlin Cross Keys Rd, Sicklerville, NJ 08081 Phone: 856-629-6453 | |
Dr. Mousumi Liza Sultana, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 589 Berlin Cross Keys Rd, Sicklerville, NJ 08081 Phone: 856-629-6453 Fax: 856-262-9174 | |
Ernest Obeng, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 416 Sicklerville Rd, Sicklerville, NJ 08081 Phone: 856-566-1100 | |
Dr. Enoch Kwasi Boateng, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10 Serene Ln, Sicklerville, NJ 08081 Phone: 917-291-4844 |